Arrowhead Pharmaceuticals saw the highest growth of 116% in patent filings in March and 179% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 74% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Arrowhead Pharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Arrowhead Pharmaceuticals has been focused on protecting inventions in Israel(IL) with seven publications in Q1 2024

The Israel(IL) Patent Office dominates the patent filings and grants with nearly 14% filings and 21% grants. The Israel(IL), Japan(JP), South Korea(KR), and United States(US) patent Office are among the top ten patent offices where Arrowhead Pharmaceuticals is filings its patents. Among the top granted patent authorities, Arrowhead Pharmaceuticals has 21% of its grants in Israel(IL), 21% in Japan(JP) and 16% in South Korea(KR).

Novo Nordisk Foundation could be the strongest competitor for Arrowhead Pharmaceuticals

In terms of grant share, Arrowhead Pharmaceuticals stands first among its competitors followed by Arrowhead Pharmaceuticals and Novo Nordisk Foundation.

Patents related to rare diseases and climate change lead Arrowhead Pharmaceuticals's portfolio

Arrowhead Pharmaceuticals has the highest number of patents in rare diseases followed by, climate change. For rare diseases, nearly 75% of patents were filed and 91% of patents were granted in Q1 2024.

Fibrosis related patents lead Arrowhead Pharmaceuticals portfolio followed by liver diseases, and carcinomas

Arrowhead Pharmaceuticals has highest number of patents in fibrosis followed by liver diseases, carcinomas, cholestasis, and liver cancer. For fibrosis, nearly 12% of patents were filed and 13% of patents were granted in Q1 2024.

For comprehensive analysis of Arrowhead Pharmaceuticals's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.